RxDoctor Payments Data

Elaine Timm

Family Medicine · Plano, TXNPI 1013001338

Payments from drug & device makers

$18,243in general payments, 2019–2025

Across 919 payments — averaging $19.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Amgen$2K
  • Teva Pharmaceuticals USA, Inc.$1K
  • Merz Pharmaceuticals, LLC$1K
  • Ipsen Biopharmaceuticals, Inc$915
  • Jazz Pharmaceuticals Inc.$801
  • plus $9K from 53 others

What the payments were for

  • Food & beverage$18,243100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)185$2,910
Amgen(2 entities)106$2,218
Teva Pharmaceuticals USA, Inc.61$1,452
Merz Pharmaceuticals, LLC44$1,379
Ipsen Biopharmaceuticals, Inc53$915
Jazz Pharmaceuticals Inc.26$801
Pfizer50$659
Merz North America, Inc.24$547
Biohaven Pharmaceuticals, Inc.21$536
Novartis27$508
Biohaven Pharmaceutical Holding Company Ltd.23$495
Lundbeck LLC25$482
Lilly USA, LLC34$462
Upsher-smith Laboratories LLC18$389
Bristol Myers Squibb7$362
Axsome Therapeutics, Inc.13$324
Supernus Pharmaceuticals, Inc.16$288
MDD US Operations, LLC22$275
UCB, Inc.16$255
Genentech USA, Inc.11$254
Bausch Health US, LLC9$227
SK Life Science, Inc.9$216
Avanir Pharmaceuticals, Inc.15$204
Sanofi10$192
Argenx US, Inc.6$180
Biogen6$127
Assertio Therapeutics, Inc.6$107
Sunovion Pharmaceuticals Inc.6$104
Revance Therapeutics, Inc.2$102
Scilex Pharmaceuticals Inc.6$101
AstraZeneca4$101
Endo Pharmaceuticals Inc.6$86
Impel Pharmaceuticals Inc.3$82
Harmony Biosciences LLC4$79
EMD Serono, Inc.3$72
Tonix Medicines, Inc.3$72
Currax Pharmaceuticals LLC4$64
Takeda Pharmaceuticals U.S.A., Inc.3$60
Mallinckrodt Enterprises LLC4$60
Inspire Medical Systems, Inc.2$55
Otsuka America Pharmaceutical, Inc.3$44
Impel Pharmaceuticals LLC2$41
Neurocrine Biosciences, Inc.2$35
Collegium Pharmaceutical, Inc.2$34
Xeris Pharmaceuticals, Inc.2$26
Sumitomo Pharma America, Inc.2$25
Aucta Pharmaceuticals, Inc.1$24
Vanda Pharmaceuticals Inc.1$24
Banner Life Sciences, LLC1$23
Merck1$21
Azurity Pharmaceuticals, Inc.1$21
Promius Pharma LLC1$19
Zyla Life Sciences, Inc.1$18
Optinose US, Inc.1$18
Vertex1$16
Abbott1$14
Shire North American Group Inc1$13
Alnylam Pharmaceuticals Inc.1$13
Amneal Pharmaceuticals LLC1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,243 in reported general payments places this provider in the 95th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
Nurtec OdtRimegepant Sulfate18$21,520
Emgality SyringeGalcanezumab-Gnlm13$21,093
Emgality PenGalcanezumab-Gnlm16$15,399
UbrelvyUbrogepant15$10,901
Candesartan Cilexetil11$1,023
Amitriptyline Hcl12$106
Montelukast Sodium12$79
Baclofen12$25
Cyclobenzaprine Hcl12$7

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerNurtec Odt$659$21,52018 claims
AbbVieUbrelvy$2,910$10,90115 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Plano

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →